-
公开(公告)号：US20210261652A1
公开(公告)日：2021-08-26
申请号：US17181997
申请日：2021-02-22
Applicant: PROTHENA BIOSCIENCES LIMITED
Inventor： Tarlochan S. Nijjar , Robin BARBOUR , Philip James DOLAN, III , Yue LIU , Svetlana ALEXANDER , Mark E. RENZ
Abstract: The invention provides antibodies that specifically bind tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.
-
Patent Agency Ranking
公开(公告)号：US20190330316A1
公开(公告)日：2019-10-31
申请号：US16097445
申请日：2017-05-02
Applicant: PROTHENA BIOSCIENCES LIMITED
Inventor： Robin BARBOUR , Philip James DOLAN , Yue LIU
Abstract: The invention provides antibodies that specifically bind tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.
-
公开(公告)号：US20210032319A1
公开(公告)日：2021-02-04
申请号：US16933792
申请日：2020-07-20
Applicant: PROTHENA BIOSCIENCES LIMITED
Inventor： Peter SEUBERT , Philip James DOLAN, III , Yue LIU , Robin BARBOUR
Abstract: The invention provides antibodies to tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.
-
公开(公告)号：US20200369755A1
公开(公告)日：2020-11-26
申请号：US16808209
申请日：2020-03-03
Applicant: PROTHENA BIOSCIENCES LIMITED
Inventor： Tarlochan S. Nijjar , Robin BARBOUR , Philip James DOLAN, III , Yue LIU , Svetlana ALEXANDER , Mark RENZ
Abstract: The invention provides antibodies that specifically bind tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.
-
公开(公告)号：US20220153821A1
公开(公告)日：2022-05-19
申请号：US17291986
申请日：2019-11-08
Applicant: PROTHENA BIOSCIENCES LIMITED
Inventor： Tarlochan S. NIJJAR , Robin BARBOUR , Philip James DOLAN, III , Yue LIU , Svetlana ALEXANDER , Mark E. RENZ
Abstract: The invention provides antibodies that specifically bind tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.
-
公开(公告)号：US20190322728A1
公开(公告)日：2019-10-24
申请号：US16092439
申请日：2017-05-02
Applicant: PROTHENA BIOSCIENCES LIMITED
Inventor： Peter SEUBERT , Philip James DOLAN, III , Yue LIU , Robin BARBOUR
Abstract: The invention provides antibodies to tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.
-
-
-
-
-
Search Results
6
records
(took 0.015 seconds)
